DK1115708T3 - Aminoalkyl-3,4-dihydriquinolinderivater som NO-synthaseinhibitorer - Google Patents

Aminoalkyl-3,4-dihydriquinolinderivater som NO-synthaseinhibitorer

Info

Publication number: DK1115708T3
Authority: DK; Denmark
Prior art keywords: dihydriquinoline; aminoalkyl; derivatives; synthase inhibitors; synthase
Prior art date: 1998-09-24

Application number

DK99948842T

Other languages

Danish (da)

English (en)

Inventor

Stefan Jaroch

Hartmut Rehwinkel

Peter Hoelscher

Detlev Suelzle

Margrit Hillmann

Gerardine Anne Burton

Fiona Mcdougall Mcdonald

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-24

Filing date

1999-09-20

Publication date

2004-08-02

1999-09-20 Application filed by Schering Ag filed Critical Schering Ag

2004-08-02 Application granted granted Critical

2004-08-02 Publication of DK1115708T3 publication Critical patent/DK1115708T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/18—Ring systems of four or more rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Hematology (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Psychology (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)

DK99948842T 1998-09-24 1999-09-20 Aminoalkyl-3,4-dihydriquinolinderivater som NO-synthaseinhibitorer DK1115708T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19845830A DE19845830A1 (de)	1998-09-24	1998-09-24	Aminoalkyl-3,4-dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln
PCT/EP1999/007091 WO2000017167A1 (fr)	1998-09-24	1999-09-20	Derives d'aminoalkyl-3,4-dihydroquinoleine en tant qu'inhibiteurs de no synthase

Publications (1)

Publication Number	Publication Date
DK1115708T3 true DK1115708T3 (da)	2004-08-02

Family

ID=7883472

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99948842T DK1115708T3 (da)	1998-09-24	1999-09-20	Aminoalkyl-3,4-dihydriquinolinderivater som NO-synthaseinhibitorer

Country Status (22)

Country	Link
US (1)	US7067667B2 (fr)
EP (1)	EP1115708B1 (fr)
JP (1)	JP2002526478A (fr)
KR (1)	KR20010075326A (fr)
CN (1)	CN1137097C (fr)
AR (1)	AR021824A1 (fr)
AT (1)	ATE264308T1 (fr)
AU (1)	AU752412B2 (fr)
BR (1)	BR9914042A (fr)
CA (1)	CA2340990A1 (fr)
DE (2)	DE19845830A1 (fr)
DK (1)	DK1115708T3 (fr)
ES (1)	ES2219067T3 (fr)
HU (1)	HUP0104151A3 (fr)
NO (1)	NO20011506L (fr)
NZ (1)	NZ510561A (fr)
PE (1)	PE20001073A1 (fr)
PL (1)	PL346838A1 (fr)
PT (1)	PT1115708E (fr)
SK (1)	SK3732001A3 (fr)
TW (1)	TW565556B (fr)
WO (1)	WO2000017167A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE59911958D1 (de)	1998-11-13	2005-05-25	Schering Ag	Fluorierte 3,4-dihydrochinolin-derivative als nos-inhibitoren
FR2865827A1 (fr) *	2004-01-29	2005-08-05	St Microelectronics Sa	Securisation du mode de test d'un circuit integre
WO2025128903A1 (fr) *	2023-12-13	2025-06-19	Eikon Therapeutics, Inc.	Nouvelle synthèse de composés tricycliques substitués

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IN153442B (fr) *	1981-12-22	1984-07-14	Hoechst Pharmaceuticals Limite
DE3305329A1 (de) *	1983-02-17	1984-08-23	Hoechst Ag, 6230 Frankfurt	Polyzyklische bisamidine, verfahren zu ihrer herstellung und ihre verwendung als chemotherapeutika
US5629322A (en) *	1994-11-15	1997-05-13	Merck & Co., Inc.	Cyclic amidine analogs as inhibitors of nitric oxide synthase
WO1997009982A1 (fr) *	1995-09-14	1997-03-20	Nippon Kayaku Kabushiki Kaisha	Inhibiteur de monoxyde d'azote synthetase qui contient des 2-aminopyridines en tant qu'ingredient actif
DE19538088A1 (de) *	1995-10-13	1997-04-17	Bernd Prof Dr Clement	Phenanthridinderivate und ihre Herstellung
WO1997036871A1 (fr) *	1996-03-29	1997-10-09	Pfizer Inc.	Derives de 6-phenylpyridyl-2-amines
DE19806348A1 (de) *	1998-02-12	1999-08-19	Schering Ag	3,4-Dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln

1998
- 1998-09-24 DE DE19845830A patent/DE19845830A1/de not_active Withdrawn
1999
- 1999-09-20 JP JP2000574077A patent/JP2002526478A/ja active Pending
- 1999-09-20 KR KR1020017003731A patent/KR20010075326A/ko not_active Ceased
- 1999-09-20 PL PL99346838A patent/PL346838A1/xx not_active Application Discontinuation
- 1999-09-20 HU HU0104151A patent/HUP0104151A3/hu unknown
- 1999-09-20 DK DK99948842T patent/DK1115708T3/da active
- 1999-09-20 TW TW088116209A patent/TW565556B/zh not_active IP Right Cessation
- 1999-09-20 EP EP99948842A patent/EP1115708B1/fr not_active Expired - Lifetime
- 1999-09-20 BR BR9914042-0A patent/BR9914042A/pt not_active IP Right Cessation
- 1999-09-20 DE DE59909194T patent/DE59909194D1/de not_active Expired - Fee Related
- 1999-09-20 CN CNB998112755A patent/CN1137097C/zh not_active Expired - Fee Related
- 1999-09-20 SK SK373-2001A patent/SK3732001A3/sk unknown
- 1999-09-20 AT AT99948842T patent/ATE264308T1/de not_active IP Right Cessation
- 1999-09-20 AU AU61955/99A patent/AU752412B2/en not_active Ceased
- 1999-09-20 ES ES99948842T patent/ES2219067T3/es not_active Expired - Lifetime
- 1999-09-20 PT PT99948842T patent/PT1115708E/pt unknown
- 1999-09-20 WO PCT/EP1999/007091 patent/WO2000017167A1/fr not_active Ceased
- 1999-09-20 CA CA002340990A patent/CA2340990A1/fr not_active Abandoned
- 1999-09-20 NZ NZ510561A patent/NZ510561A/en unknown
- 1999-09-21 PE PE1999000954A patent/PE20001073A1/es not_active Application Discontinuation
- 1999-09-24 AR ARP990104826A patent/AR021824A1/es unknown
2001
- 2001-03-23 NO NO20011506A patent/NO20011506L/no not_active Application Discontinuation
2003
- 2003-10-29 US US10/694,845 patent/US7067667B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU6195599A (en)	2000-04-10
DE59909194D1 (en)	2004-05-19
KR20010075326A (ko)	2001-08-09
CN1137097C (zh)	2004-02-04
PL346838A1 (en)	2002-02-25
DE19845830A1 (de)	2000-03-30
JP2002526478A (ja)	2002-08-20
NO20011506L (no)	2001-05-23
US20040127712A1 (en)	2004-07-01
HUP0104151A2 (hu)	2002-03-28
EP1115708B1 (fr)	2004-04-14
NZ510561A (en)	2003-11-28
PE20001073A1 (es)	2000-10-18
EP1115708A1 (fr)	2001-07-18
ATE264308T1 (de)	2004-04-15
HUP0104151A3 (en)	2002-06-28
SK3732001A3 (en)	2001-12-03
TW565556B (en)	2003-12-11
BR9914042A (pt)	2001-06-19
NO20011506D0 (no)	2001-03-23
US7067667B2 (en)	2006-06-27
AR021824A1 (es)	2002-08-07
PT1115708E (pt)	2004-08-31
AU752412B2 (en)	2002-09-19
CA2340990A1 (fr)	2000-03-30
WO2000017167A1 (fr)	2000-03-30
CN1319093A (zh)	2001-10-24
ES2219067T3 (es)	2004-11-16

Publication	Publication Date	Title
DK2253620T3 (da)	2014-03-31	Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer
DK1244647T3 (da)	2006-09-25	Quinzolinderivater som VIGF-inhibitorer
NO20021239D0 (no)	2002-03-13	Pteridinoner som kinase-inhibitorer
DK1114032T3 (da)	2004-08-16	4-aminosubstituerede-2-substituerede-1,2,3,4-tetrahydroquinoliner som CETB-inhibitorer
NO20015065D0 (no)	2001-10-18	Pyrazolobenzodiazepiner som CDK2-inhibitorer
DK1220831T3 (da)	2005-08-29	Biaryletherderivater, der er nyttige som monoamingenoptagelsesinhibitorer
DK0946512T3 (da)	2004-01-12	6-Phenylpyridyl-2-aminderivater, der er nyttige som NOS-inhibitorer
NO20023828L (no)	2002-09-30	Pyrimidin-4-on derivater som LDL-PLA2 inhibitorer
DK1140840T3 (da)	2006-07-31	omega-carboxyaryl-substituerede diphenylurinstoffer som raf-kinase-inhibitorer
NO20031006L (no)	2003-03-04	Imidazolo-5-yl-2-anilino-pyrimidiner som midler for inhibering av celleproliferasjon
NO20030055D0 (no)	2003-01-06	Colchinolderivater som angiogenese inhibitorer
NO20012701D0 (no)	2001-06-01	Aryl- og heterosyklylsubstituerte pyrimidinderivater som antikoagulanter
PT1056759E (pt)	2003-01-31	Derivados do 2-(purin-9-il)-tetrahidrofurano-3,4-diolc
DK1337527T3 (da)	2010-01-04	Indolylmaleinimidderivater som proteinkinase C-inhibitorer
NO20015477D0 (no)	2001-11-08	4,5,6,7-tetrahydroindazol-derivater som anti-tumor midler
TR200000520A3 (tr)	2001-06-21	4-Fenil-piridin türevleri.
NO20025525D0 (no)	2002-11-18	Substituerte pyrrolpyridinonderivater, brukbare som fosfordiesterase-inhibitorer
MXPA03008807A (es)	2004-02-12	Derivados de ciclopropilindol como inhibidores selectivos de recaptacion de serotonina.
DK1097127T3 (da)	2003-06-10	Diacylhydrazinderivater som integrininhibitorer
NO20033618D0 (no)	2003-08-14	Ftalayinon-piperidino-derivater som PDE-4-inhibitorer
NO20003451D0 (no)	2000-07-04	2,3-substituerte indolforbindelser som cox-2 inhibitorer
NO20030842L (no)	2003-04-28	Fenoksybenzylaminderivater som selektive serotonin- gjenopptaksinhibitorer
NO20021407D0 (no)	2002-03-21	Bifenylderivater anvendt som NHE-3-inhibitorer
NO20016201D0 (no)	2001-12-18	Tienopyrimidiner som fosfodiesteraseinhibitorer
DK1104762T3 (da)	2002-10-21	Substituerede imidazo[1,2a]aziner som selektive COX-2-inhibitorer